(Q45888905)

17 December 2017

title

CD2 is a dominant target for allogeneic responses (English)

1 reference

17 December 2017

author name string

Yalai Bai

1

1 reference

17 December 2017

Shuang Fu

2

1 reference

17 December 2017

Shaun Honig

3

1 reference

17 December 2017

Yinong Wang

4

1 reference

17 December 2017

Lihui Qin

5

1 reference

17 December 2017

Dan Chen

6

1 reference

17 December 2017

Jonathan S Bromberg

7

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

17 December 2017

American Journal of Transplantation

published in

1 reference

17 December 2017

volume

2

1 reference

17 December 2017

issue

7

1 reference

17 December 2017

page(s)

618-626

1 reference

17 December 2017

Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

Recruitment of Activated p56lckon Endosomes of CD2-triggered T Cells, Colocalization with ZAP-70

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

The structure and ligand interactions of CD2: implications for T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

Activation of murine epidermal gamma delta T cells through surface 2B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

Activating interactions in human NK cell recognition: the role of 2B4-CD48

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

CD48-deficient mice have a pronounced defect in CD4(+) T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes

21 January 2018

2 references

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

21 January 2018

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

7 January 2021

Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

Cutting edge: Regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

7 January 2021

Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

7 January 2021

The tyrosine kinase activity of p56lck is increased in human T cells activated via CD2

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

7 January 2021

Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

7 January 2021

Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

7 January 2021

Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

7 January 2021

CD2 and CD3 receptor-mediated tolerance: constraints on T cell activation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.20706.X

7 January 2021

10.1034/J.1600-6143.2002.20706.X

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

12201362

1 reference

17 December 2017